Hi, I'm Mike. I live in Colorado with my family and 2 dogs. You'll find a little of everything here so spend some time and look around. I'm glad you stopped by.
The good news is that the IPO market for biotech stocks is receptive to new offerings. The bad news is that the valuations and size of the offerings are well below expectations. This usually means that 1) your bankers aren’t … Continue reading
I just finished reading The Big Short: Inside the Doomsday Machine by Michael Lewis. This book is a fascinating look at the creation and collapse of the subprime mortgage market that subsequently led to the market collapse in 2008 and … Continue reading
I had two thoughts when I saw this AP photo of Goldman Sachs’ CEO Lloyd Blankfein testifying before the Senate yesterday. The first was can you imagine testifying before the Senate with hoard of photographers in your face. It’s not … Continue reading
Last week I blogged Is Biotech Dead As We Know It? I posed the question whether the market dynamics have changed such that the fundamental biotech model will be altered going forward? Let’s look at that. I believe the short … Continue reading
Ten years ago today I was waiting receive comments from the SEC on an S-1 filing for an IPO. Times were bright, the biotech bubble was inflating, but had not quite burst. The bubble burst on March 28, 2000 one … Continue reading
As if public companies already didn’t have enough reporting requirements the SEC is about to release new regulations governing the disclosures around executive compensation. Over the past several years the disclosure on corporate pay policies has become refined. Proxies have … Continue reading